INTRODUCTION
Disruption of intestinal homeostasis, intestinal epithelial cell (IEC) damage, and changes in the microbiota (dysbiosis) [1] [2] [3] [4] [5] are associated with HIV-1 infection. IEC damage leads to translocation of dysbiotic microbes, 6 and microbial translocation is linked to tissue and systemic immune activation and predicts disease progression in untreated HIV-1-infected persons. [7] [8] [9] [10] Understanding the mechanisms that drive IEC damage and microbial translocation will be critical to controlling both gut and systemic inflammation during HIV-1 infection.
Maintenance of intestinal barrier integrity and homeostasis relies in part on the presence of interleukin (IL)-22. 11, 12 Depletion of gut T-helper 22 (Th22) and Th17 cells, subsets of which coproduce IL-22, is considered to be a major contributor to HIV-1 pathogenesis. 1, [13] [14] [15] A pivotal publication by Cella et al described non-T cells capable of producing IL-22 in human mucosa-associated lymphoid tissues. 16 These non-T cells identified by the expression of an NK cell activation receptor NKp44 17 and the classic NK cell marker CD56 were termed NK22 cells. NK22 cells are now considered members of the recently identified family of Group 3 innate lymphoid cells (ILC3s), which play important and diverse roles in mucosal immunity. [18] [19] [20] In untreated HIV-infected individuals, frequencies of colonic IL-22-expressing non-T cells that included NKp44 + cells were increased early in infection. 13 Furthermore, frequencies of NKp44 + IL-22-producing cells correlated with an intact intestinal barrier in long-term antiretroviral therapy-treated HIV-infected persons. 21 Thus, NKp44 + ILCs may also play a critical role in regulating epithelial barrier health during HIV infection.
Multiple studies have suggested that ILCs, including ILC3s, display a degree of functional plasticity and can produce inflammatory cytokines [eg, tumor necrosis factor alpha (TNFa) and interferon gamma (IFNg)] in response to the local cytokine milieu (eg, IL-2, IL-23, IL-12p70, IL-1b, and IL-18) and/or exposure to stimulatory signals (eg, ligation of NKp44). [22] [23] [24] [25] We have previously demonstrated that colonic myeloid dendritic cells (mDCs) produce IL-23 and IL-1b in response to exogenous exposure to mucosa-associated colonic commensal bacteria that are increased in relative abundance in untreated HIV-1-infected persons. 26 Moreover, HIV-1 induces the expression of NKp44L on CD4 T cells both in vitro and in vivo. [27] [28] [29] These observations raise the possibility that a microenvironment exists in the gut of HIV-1-infected persons that is conducive to IL-22-producing ILCs switching into inflammatory ILCs. Indeed, colonic NKp44 + ILCs demonstrated an altered phenotype by producing IFNg rather than IL-17/IL-22 during pathogenic Simian Immunodeficiency Virus (SIV) infection. 30, 31 Therefore, we evaluated the frequencies of IL-22-producing, IL-17-producing, and IFNgproducing colonic NKp44-expressing ILCs in the setting of untreated chronic HIV-1 infection.
METHODS

Study Participants
Untreated, chronically HIV-1-infected adults and HIV-1-seronegative (uninfected) controls were enrolled in this cross-sectional study at the University of Colorado Anschutz Medical Campus. Inclusion and exclusion criteria were extensively detailed in previous publications. 26, 32, 33 All study participants voluntarily provided written informed consent. This study was approved by the Colorado Multiple Institutional Review Board (COMIRB).
Surface and Intracellular Flow Cytometry Staining Assays, Acquisition, and Analysis
The collection, processing, and storage of colon biopsies are detailed elsewhere. 26 
Enumeration of Immunological, Virological, and Microbial Parameters
Measurements of plasma IL-6, C-reactive protein, TNFa, IFNg, IL-10, soluble CD14, lipoteichoic acid, lipopolysaccharide and intestinal fatty acid-binding protein, colonic mucosa levels of HIV-1 RNA, frequencies of colonic mDC, plasmacytoid DC, CD4 and CD8 T cells, measurements of mDC activation/maturation (CD40/CD83) and T-cell activation (CD38 + HLA-DR + ), and frequencies of IFNg-expressing, IL-22-expressing, and IL-17-expressing Th cells have been previously published. 26, 32, 33 Laboratory and analytic methods used to profile the intestinal microbiomes were as described. 26, 32, 33, 35 
Statistical Analysis
Nonparametric statistics were performed with no adjustments for multiple comparisons because of the exploratory nature of this study. Analyses were performed using GraphPad Prism version 6 for Windows (GraphPad Software, San Diego, CA). P value ,0.05 was considered statistically significant.
RESULTS
Absolute numbers of colonic ILCs and cytokineexpressing colonic ILCs were determined in a subset of untreated HIV-1-infected (N = 22) and uninfected (N = 10) study participants from a previously detailed clinical study. 26, 32, 33 Study participant characteristics are detailed in Table S1 , Supplemental Digital Content, http://links.lww.com/QAI/B73.
Absolute Numbers of Colonic ILCs
There were no significant differences in the absolute number of colonic NKp44 + CD56 2 and NKp44 + CD56 + ILCs between uninfected and HIV-1-infected subjects (Fig. S2 , Supplemental Digital Content, http://links.lww.com/QAI/B73). Conversely, HIV-1-infected individuals had significantly fewer NKp44 2 CD56 + cells compared with uninfected controls.
Cytokine Profiles of Colonic ILCs in Healthy Individuals
We first compared absolute numbers of IL-22-expressing, IL-17-expressing, and IFNg-expressing CD3 2 ILCs in healthy uninfected persons (Fig. 1A) 
Altered ILC Cytokine Profiles in HIV Infection
In HIV-1-infected individuals, comparable numbers of NKp44 + CD56 2 ILCs expressed IL-22 or IFNg (Fig. 1B) (Fig. 1B) .
We next compared the absolute number of cytokineproducing ILCs between uninfected and HIV-1-infected persons. IFNg-producing NKp44 + CD56 2 and NKp44 + CD56 + ILCs were significantly increased in number in HIV-1-infected relative to uninfected persons (Figs. 2A, C) . Absolute numbers of IFNg + NKp44 2 CD56 + ILCs were not statistically different between the 2 cohorts (data not shown). Numbers of IL-22-expressing NKp44 + CD56 2 or NKp44 + CD56 + ILC populations were not significantly different between HIV-1-infected and uninfected study participants (Fig. 2E) . Although numbers of IL-22-expressing NKp44 2 CD56 + cells were low compared to IFNg + NKp44 2 CD56 + cells, significantly fewer of these cells were observed in HIV-1-infected persons (Fig. 2E) . No statistical differences between uninfected and HIV-1-infected individuals in the absolute numbers of IL-17-expressing ILC populations were noted (data not shown).
Associations of IFNg-Expressing Colonic ILCs With Dysbiotic Microbes and Markers of Immune Activation in HIV-1 Infection
Given the finding of increased IFNg + ILCs in HIVinfected persons, we next addressed associations of these ILC populations with previously reported measures of clinical, virological, immunological, and microbiome indices for the HIV-1-infected cohort 26, 32, 33 (Table S2 , Supplemental Digital Content, http://links.lww.com/QAI/B73). Absolute numbers of colonic IFNg + NKp44 + CD56 2 ILCs significantly correlated with the relative abundance of Xanthomonadaceae and Prevotellaceae families, with the Prevotella genus (Fig. 2B) , and with the individual species Prevotella copri and Prevotella stercorea (R = 0.68, P = 0.01; R = 0.63, P = 0.02, respectively; data not shown). Numbers of IFNg + NKp44 + CD56 2 ILCs inversely correlated with the percentages of CD83 + CD1c + mDC (R = 20.51, P = 0.03) and positively correlated with numbers of IFNg-producing CD4 T cells (R = 0.53, P = 0.01) (data not shown). IFNg + NKp44 + CD56 + ILC numbers were not significantly associated with dysbiotic microbes but instead positively correlated with colon CD1c + mDC activation levels and with absolute numbers of activated colon CD4 and CD8 T cells in HIV-1-infected individuals (Fig. 2D) .
DISCUSSION
This study highlights that untreated, chronic HIV-1 infection is associated with higher numbers of colonic NKp44 + ILCs that express IFNg. The difference in the number of these cells expressing IFNg is unlikely related to an increase in the number of NKp44 + ILCs, given that no significant difference in the overall number of each NKp44 + ILC subsets was observed between the 2 cohorts. IFNg is an inflammatory cytokine that increases intestinal epithelial barrier permeability primarily through alterations in tight junction protein expression and thereby enhances bacterial transcytosis. [37] [38] [39] Accordingly, the presence of these inflammatory ILCs likely contributes to epithelial barrier breakdown and the resultant microbial translocation.
We, and others, have demonstrated that alterations in intestinal mucosa-associated bacterial communities during HIV-1 infection are associated with indicators of mucosal HIV-1 pathogenesis (reviewed in Ref. 40 ). In our study, major findings from the microbiome analysis included higher relative abundance of mucosa-associated bacteria belonging to the Proteobacteria phylum (including Xanthomonadaceae) and of Prevotella spp. in HIV-1-infected persons. 26, 33 Increased relative abundance of P. spp. in HIV-1-infected persons associated with increased colonic mDC and T-cell activation. 26, 33 Other HIV-associated mucosal abnormalities included decreased percentages of colonic mDC expressing CD83, 26 a molecule reported to play a role in intestinal immune regulation. 41 In this current study, numbers of IFNg-expressing NKp44 + ILCs positively correlated with relative abundances of bacterial species in the Xanthomonadaceae and Prevotellaceae families, with colonic mDC and T-cell activation and inversely associated with the fraction of colonic mDCs expressing CD83. We have previously shown that enteric bacterial species found in high abundance in HIV-1-infected persons (eg, Prevotella) are capable of inducing IL-23 and IL-1b from colonic mDC in vitro, 26 cytokines that contribute to the induction of inflammatory cytokines such as IFNg and TNFa by ILCs. 25, 42 Thus, we hypothesize that in the setting of HIV-1 infection, the shift in the phenotype of primarily IL-22-producing ILCs to IFNg-producing ILCs is linked to an intricate relationship between translocating bacteria, colonic mDC, and other signals within the inflammatory environment (eg, NKp44L).
In contrast to the dramatic alterations in numbers of IFNg-expressing NKp44 + ILCs associated with HIV-1 infection, absolute numbers of IL-22-expressing NKp44 + cells were similar in both HIV-1-infected and uninfected individuals, an observation in keeping with a number of other studies investigating gut ILCs during HIV-1 infection. 13, 21, 43, 44 Conversely, 1 study which identified colonic tissue ILCs as CD3 2 IL-22 + using immunohistological techniques found decreased numbers of these cells in untreated HIV-1-infected versus uninfected individuals. 45 In contrast to HIV-1 infection, both absolute frequencies of ILCs and frequencies of IL-22-/ IL-17-producing ILCs were significantly reduced during early and chronic SIV infection. 30, 31, [46] [47] [48] Of note, we observed a decrease in frequencies of NKp44 2 CD56 + cells that expressed IL-22, likely related to the overall decrease in absolute numbers of colonic NKp44 2 CD56 + cells as a whole. However, NKp44 2 CD56 + cells do not typically produce IL-22, so the impact of an overall decrease in this small population in untreated, chronic HIV-1-infected persons may be minor in the context of maintenance of IL-22 + NKp44 + ILCs.
We acknowledge a number of limitations to this pilot study. The study was not powered to address alterations in numbers of colonic cytokine-producing ILCs in the setting of HIV-1 infection. The 2 study groups were not matched for sexual practice, which has recently been reported to affect the intestinal microbiome independent of HIV-1 infection 49, 50 and may drive mucosal immune cell activation and inflammation 50 and therefore be a contributing factor to our current observations. Enumeration of the specific ILC subsets was based on criteria used to identify NK22 cells. 16 Since that time, the field of ILC biology has greatly expanded, and a more rigorous and specific identification paradigm for the various ILC subsets (ie, NK, ILC1s, ILC2, and ILC3s) is being used. 19, 20, 42, 51, 52 Our ability to determine the composition of the specific ILC subsets (NK vs ILC1 vs ILC3) within the cytokine-producing populations based on this more recent nomenclature is limited here, and future studies will be needed to incorporate these most recent definitions.
Despite these limitations, the observations that higher frequencies of IFNg-producing ILCs, particularly in the NKp44 + CD56 2 ILC population which typically does not produce IFNg in the absence of HIV-1 infection, underscore the role these innate immune cells may play in HIV-1-associated mucosal inflammation and pathogenesis. Additional studies both in vivo and in vitro will be required to determine the extent to which the increased numbers are a result of a switch from IL-22 to IFNg production versus expansion of the IFNg-producing population versus an influx of inflammatory cells into the mucosal tissue. In summary, higher numbers of inflammatory colonic ILCs during untreated chronic HIV-1 infection associate with dysbiosis and gut mDC and T-cell activation suggesting a critical interplay between gut ILCs, the microbiome, and local immune responses that should be further explored.
